Adnexal Diseases: Clinical Trials

3 trials for Adnexal Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 suspended. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Suspended 3
Phase 11Suspended 1

Follow Adnexal Diseases: new trials by email Literature Review of Adnexal Diseases trials Research Report on Adnexal Diseases

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor
Lucitanib, Nivolumab - Advanced Solid Tumor, Gynecologic Cancer
Phase 1 / Phase 2SuspendedClovis Oncology, Inc.2272019-07-292022-12-20
Montelukast for Prevention & Treatment of OHSS
dydrgesterone 10 mg( tab)/12hs/14 days, montelukast 10 mg(tab) oral/24hs/ 7 days dydrgesterone 10 mg( tab) oral/12hs/14 days - Ovarian Hyperstimulation Syndrome
Phase 2SuspendedBenha University202018-12-052022-09-21
The Safety and Efficiency Study of Mesenchymal Stem Cell (19#iSCLife®-POI) in Premature Ovarian Insufficiency
hucMSCs - Premature Ovarian Failure
Phase 2SuspendedSclnow Biotechnology Co., Ltd.122018-10-012026-04-23

Narrower conditions

Endometrial Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Genital Neoplasms, Female (1)  ·  Ovarian Hyperstimulation Syndrome (1)  ·  Ovarian Neoplasms (1)  ·  Primary Ovarian Insufficiency (1)  ·  Uterine Cervical Neoplasms (1)

Broader conditions

Endocrine System Diseases (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genital Diseases (3)  ·  Genital Diseases, Female (3)  ·  Gonadal Disorders (3)  ·  Ovarian Diseases (3)  ·  Urogenital Diseases (3)  ·  Endocrine Gland Neoplasms (1)  ·  Fallopian Tube Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Urogenital Neoplasms (1)  ·  Uterine Cervical Diseases (1)

Interventions

E-3810 (1)  ·  Nivolumab (1)  ·  Tablets (1)  ·  montelukast (1)

Sponsors

Benha University (1)  ·  Clovis Oncology, Inc. (1)  ·  Sclnow Biotechnology Co., Ltd. (1)

Countries

Austria (1)  ·  Belgium (1)  ·  China (1)  ·  Egypt (1)  ·  Germany (1)  ·  Italy (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Erika Hamilton, MD (1)  ·  Guangzhi Liu, Dr (1)  ·  Nicole Concin, MD (1)